{"SPADE_UN_08087": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 7001924 B2", "Patent Link": "http://www.lens.org/lens/patent/US_7001924_B2", "Patent Type": "Granted Patent", "Publication Date": "2006-2-21", "Family Info": "EP1435932A2,EP1435932A4,US20030134904,WO2003024407A2,WO2003024407A3", "Patent Title": "Inhibitors of RNase P proteins as antibacterial compounds.", "Abstract": "The present invention features compounds useful for inhibiting RNase P activity. These compounds can be used as therapeutics for treating or preventing a variety of bacterial infections. The compounds belong to several classes including mono- and bis-guanylhydrazones, guanylhydrazone mimetics, and benzothiazolium compounds. Exemplary compounds are compounds of formula I: \nYâ€”(NRâ€²)kâ€”U1â€”(NRâ€³)Iâ€”Aâ€”(NR1)mâ€”U2â€”(NR2)nâ€”Zâ€ƒâ€ƒI with substituents as described herein."}], "Sequence Information": {"SPADE ID": "SPADE_UN_08087", "Sequence": "NRLRRREDFATAVRAGFVVSKAVGGAVVRNQVKRRLKHLVCDRLSALLVVVRALPGAGDADHAQLARDLD", "Sequence Length": 70, "Peptide Name": "Sequence 83 from Patent US 7001924", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial"], "Frequent Amino Acids": "ARV", "Absent Amino Acids": "IMOUWY", "Basic Residues": 16, "Acidic Residues": 7, "Hydrophobic Residues": 34, "Polar Residues": 46, "Positive Residues": 16, "Negative Residues": 7, "Mass": 7644.79, "PI": 11.38, "Net Charge": 9, "Hydrophobicity": -0.05, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_08088", "Similarity": 0.8857142857142857, "Sequence": "NRLRRREDFATAVRAGFVVSKAVGVAVVRNKVKRRLRHLMRDRIDLLLVVVRALPGAGDADHAQLARDLD"}, {"SPADE_ID": "SPADE_UN_18511", "Similarity": 0.782608695652174, "Sequence": "NRLRRREDFARAGFVVSKAVGGAVVRNQVKRRLRHLPLVVVLARDL"}, {"SPADE_ID": "SPADE_UN_18512", "Similarity": 0.7391304347826086, "Sequence": "NRLRRREDFARAGFVVSKAVGVAVVRNKVKRRLRHLPLVVVLARDL"}]}}}